CCS offers a diverse portfolio of programs that support leading-edge research across all types of cancer and all stages of the cancer journey. Funded areas include, but are not limited to:
- biological studies (biochemistry, genetics, immunology, epigenetics, genomics, and molecular biology of cancer)
- chemical studies (medicinal chemistry, experimental therapeutics, drug development, and drug delivery)
- physical sciences (biophysics imaging, radiobiology, photobiology, nanotechnology, machine learning, and robotics)
- clinical sciences (chemotherapy, (digital) pathology, psychology, and psychosocial studies)
- population health sciences (community health, health promotion, health services, epidemiology and occupational/ environmental health sciences, health economics)
- translational research (rapidly moving research results into better treatments, prevention, and risk reduction strategies)
- cancer prevention, early detection, screening, diagnosis, treatment, rehabilitation, related psychosocial issues, complementary and alternative medicine
- knowledge mobilization, such as the development and testing of programs and interventions based on research evidence
- research which could lead to improvements in the quality of life of people with cancer, for example, improving supportive care, survivorship, and end-of-life and palliative care
Applicants must hold a firm academic position (as a primary appointment) in an eligible Canadian Host Institution such as a university, research institute or health care agency. Only investigators meeting this criterion can apply for funds.
CCS offers grant competitions in a variety of program areas. Each of these requires a formal application and is subject to specific eligibility and other requirements. All applications are submitted online through EGrAMS, our grants administration and management system.
Applicants will be notified by email of the status of their applications. Successful applications will be listed on the website alphabetically by the Principal Investigator’s surname for each competition and will receive an official notification directly. Co-Principal Investigators, Co-Applicants, Additional Authors and Survivor/Caregiver participants will not be posted on the website. Once results are announced, applicants will be able to access the reviewer reports in EGrAMS.
Some programs require letters of intent or abstract registration. Please consult the program description pages for specific requirements.
Peer review committees are composed of diverse (gender, geography, career stage, race) scientists with expertise relevant to the research program, and patient/survivor/caregiver representatives who evaluate the relevance of the proposed work to cancer and those affected by it. Where possible, CCS strives to assemble panels that are representative of the application pool.